These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29171490)

  • 21. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
    Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
    J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.
    Min W; Li T; Ma X; Li Z; Yu T; Gao D; Zhang B; Yun Y; Sun X
    Psychopharmacology (Berl); 2009 Aug; 205(3):409-17. PubMed ID: 19468717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
    Yoshimura R; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Katsuki A; Atake K; Nakamura J
    Hum Psychopharmacol; 2013 Sep; 28(5):466-70. PubMed ID: 23813968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].
    Higuchi H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):71-6. PubMed ID: 20491280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].
    Cvjetković-Bosnjak M; Knezević A; Soldatović-Stajić B
    Med Pregl; 1999; 52(3-5):108-11. PubMed ID: 10518394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder.
    Ramesh V; Venkatesan V; Ramasamy B
    Hum Psychopharmacol; 2022 Jul; 37(4):e2830. PubMed ID: 34994008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quantitative review on outcome-to-antidepressants in melancholic unipolar depression.
    Valerio MP; Szmulewicz AG; Martino DJ
    Psychiatry Res; 2018 Jul; 265():100-110. PubMed ID: 29702301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Could pharmacogenetics play a role as predictor in treatment of depressive disorders?
    Lee MS
    World J Biol Psychiatry; 2007; 8(1):2-3. PubMed ID: 17366343
    [No Abstract]   [Full Text] [Related]  

  • 29. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
    Strohmaier J; Wüst S; Uher R; Henigsberg N; Mors O; Hauser J; Souery D; Zobel A; Dernovsek MZ; Streit F; Schmäl C; Kozel D; Placentino A; Farmer A; McGuffin P; Aitchison KJ; Rietschel M
    World J Biol Psychiatry; 2011 Oct; 12(7):528-38. PubMed ID: 21388237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SERT and NET polymorphisms, temperament and antidepressant response.
    Andre K; Kampman O; Illi A; Viikki M; Setälä-Soikkeli E; Mononen N; Lehtimäki T; Haraldsson S; Koivisto PA; Leinonen E
    Nord J Psychiatry; 2015; 69(7):531-8. PubMed ID: 25739526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients.
    Serretti A; Kato M; De Ronchi D; Kinoshita T
    Mol Psychiatry; 2007 Mar; 12(3):247-57. PubMed ID: 17146470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
    Perry PJ
    J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.
    Weizman A; Weizman R
    Pharmacogenomics; 2000 Aug; 1(3):335-41. PubMed ID: 11256582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.
    Smits KM; Smits LJ; Schouten JS; Stelma FF; Nelemans P; Prins MH
    Mol Psychiatry; 2004 May; 9(5):433-41. PubMed ID: 15037864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoxetine response in impulsive-aggressive behavior and serotonin transporter polymorphism in personality disorder.
    Silva H; Iturra P; Solari A; Villarroel J; Jerez S; Jiménez M; Galleguillos F; Bustamante ML
    Psychiatr Genet; 2010 Feb; 20(1):25-30. PubMed ID: 20010449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.
    Tomita T; Yasui-Furukori N; Nakagami T; Tsuchimine S; Ishioka M; Kaneda A; Sugawara N; Kaneko S
    PLoS One; 2014; 9(5):e98099. PubMed ID: 24858363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Study Between Serotonin Transporter Gene and Fluoxetine Response in Mexican Patients With Major Depressive Disorder.
    Camarena B; Álvarez-Icaza D; Hernández S; Aguilar A; Münch L; Martínez C; Becerra-Palars C
    Clin Neuropharmacol; 2019; 42(1):9-13. PubMed ID: 30520759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
    Song F; Freemantle N; Sheldon TA; House A; Watson P; Long A; Mason J
    BMJ; 1993 Mar; 306(6879):683-7. PubMed ID: 8471919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot study.
    Popp J; Leucht S; Heres S; Steimer W
    Pharmacogenomics; 2006 Mar; 7(2):159-66. PubMed ID: 16515395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
    Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
    Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.